119th Congress · introduced in the House · Mar 31, 2025
SUPPORT for Patients and Communities Reauthorization Act of 2025
Official title from Congress.gov
Latest action (Dec 1, 2025): Became Public Law No: 119-44.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Public Law (Dec 1, 2025) · 2 versions published
SUPPORT for Patients and Communities Reauthorization Act of 2025
This act reauthorizes and revises programs and activities relating to addressing substance use disorders, overdoses, and mental health. (For additional information on each section of this act, see CRS Report R48864.)
TITLE I--PREVENTION
(Sec. 101) This section reauthorizes through FY2030 Centers for Disease Control and Prevention (CDC) programs that provide information, grants, and technical assistance relating to studying and preventing prenatal and postnatal substance use disorders.
(Sec. 102) This section reauthorizes through FY2030 CDC programs that carry out and provide grants for surveillance, treatment, and education relating to infections associated with illicit drug use.
(Sec. 103) This section reauthorizes through FY2030 and expands CDC programs that carry out activities and provide grants relating to monitoring drug use and overdoses (e.g., supporting state prescription drug monitoring programs), preventing and responding to substance use disorders, and raising awareness regarding opioids and other substances.
The section authorizes additional activities, including wastewater surveillance and collecting data on risk factors associated with overdoses.
(Sec. 104) This section reestablishes, expands, and provides statutory authority for Department of Health and Human Services (HHS) activities addressing fetal alcohol spectrum disorders (i.e., conditions caused by prenatal alcohol exposure), including carrying out and providing grants for research, education and public awareness, and intervention and support services for affected individuals.
(Sec. 105) This section specifies that, in providing grants to support state prescription drug monitoring programs, the CDC is not authorized to require states to use specific vendors or interoperability systems other than to align with general, consensus-based standards for interoperability.
(Sec. 106) This section reauthorizes through FY2030 and expands grants to government entities to provide first responders with opioid overdose reversal drugs (e.g., naloxone) and related training. The grant program is administered by the Substance Abuse and Mental Health Services Administration (SAMHSA).
The section expands the program to include (1) treatment and training for overdoses from other drugs besides opioids, and (2) treatment with drugs or devices that are legally marketed under applicable law. Current law limits the program to addressing opioid overdoses and to drugs or devices that are officially approved or cleared by the Food and Drug Administration (FDA).
(Sec. 107) This section reauthorizes through FY2030 and revises the National Child Traumatic Stress Initiative and related activities, which are administered by SAMHSA. Under the initiative, SAMHSA provides grants and other support to improve the quality of and increase access to services addressing psychological trauma in youth and families.
The section requires grant recipients to develop training and other resources for collaborative implementation of best practices.
(Sec. 108) This section requires SAMHSA to undertake efforts to protect the 9-8-8 Suicide & Crisis Lifeline from cybersecurity threats. (The lifeline is a three-digit number that connects callers in suicidal crisis or mental health distress to a national network of crisis centers.) The section includes requirements for the lifeline’s network administrator and participating local and regional crisis centers to report identified cybersecurity incidents and vulnerabilities.
The Government Accountability Office must conduct a study that evaluates cybersecurity risks and vulnerabilities associated with the lifeline and report the findings to Congress.
(Sec. 109) This section reauthorizes through FY2030 CDC activities to collect and report certain public health data relating to potentially traumatic childhood experiences.
(Sec. 110) This section reauthorizes through FY2030 an interdepartmental committee on substance use disorders, establishes an interagency work group on fentanyl contamination of illegal drugs, and expands certain SAMHSA activities to include supporting strategies to raise awareness about the dangers of synthetic opioids for youth.
(Sec. 111) This section requires HHS to publish guidance regarding at-home safe drug disposal systems.
(Sec. 112) This section requires HHS to publish a plan for assessing approved opioid analgesic drugs (i.e., opioid pain relievers) that addresses the public health effects of these drugs, including updates on actions by the FDA with respect to risk-benefit assessments and supporting development and approval of nonaddictive medical products. HHS must provide an opportunity for public input on the FDA’s regulation of opioid analgesic drugs.
(Sec. 113) This section provides statutory authority for SAMHSA’s State Opioid Response and Tribal Opioid Response Grants to be used for facilitating access to drug checking technologies, such as fentanyl and xylazine test strips, to the extent permitted by federal and state law.
TITLE II--TREATMENT
(Sec. 201) This section reauthorizes through FY2030 the Residential Treatment for Pregnant and Postpartum Women program, which is administered by the Center for Substance Abuse Treatment within SAMHSA. This program awards grants to fund services for pregnant and postpartum women with substance use disorders, including services for treatment, recovery support, and case management.
The section also specifically allows grant recipients to conduct outreach that is targeted at women disproportionately impacted by maternal substance use disorders.
(Sec. 202) This section provides statutory authority for the Minority Fellowship Program to include fellowships for training in the field of addiction medicine. The Minority Fellowship Program, administered by SAMHSA, funds fellowships for individuals seeking graduate degrees and planning to work on addressing mental or substance use disorders in racial and ethnic minority populations.
(Sec. 203) This section reauthorizes through FY2030 the Behavioral Health Workforce Education and Training Program for Professionals, which is administered by the Health Resources and Services Administration (HRSA). This program provides grants to educational organizations and programs to recruit and educate students in mental and behavioral health.
(Sec. 204) This section reauthorizes through FY2030 the Substance Use Disorder Treatment and Recovery Loan Repayment Program, which is administered by HRSA. This program provides repayment of educational loans for health care practitioners who agree to provide direct treatment or recovery support for substance use disorders in certain areas with shortages of health professionals or high rates of overdose.
(Sec. 206) This section reauthorizes through FY2030 and expands an interagency task force that must develop recommendations relating to (1) best practices for preventing and mitigating trauma in youth and (2) coordinating the federal response to families impacted by substance use disorders and other trauma.
(Sec. 208) This section requires SAMHSA to conduct a review of how states use funds under the Community Mental Health Services Block Grant program to address first episode psychosis, including the use of evidence-based services for individuals with early serious mental illness and children with serious emotional disturbance. SAMHSA must report to Congress on the findings of the review and update the guidance for the block grant program based on such findings.
(Sec. 209) This section requires HHS to review relevant data and, if determined appropriate, request that the Drug Enforcement Administration (DEA) revise the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act. The DEA must review such requests and determine whether to revise the schedules.
(Sec. 210) This section requires that, when HHS issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the FDA.
Within one year after the act’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the act’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention.
(Sec. 211) This section requires HHS to convene a public roundtable with public and private stakeholders on expanding the use of electronic health records among mental health and substance use disorder service providers. HHS must report to Congress on the results of the roundtable with respect to specified topics.
TITLE III--RECOVERY
(Sec. 301) This section reauthorizes through FY2030 the Building Communities of Recovery program, which is administered by the Center for Substance Abuse Treatment within SAMHSA. This program provides grants to certain community nonprofit organizations for developing and delivering coordinated community and statewide recovery support services for individuals with substance use disorders.
(Sec. 302) This section reauthorizes through FY2030 and expands the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support, which is administered by SAMHSA. The center provides training and resources to public and private nonprofit entities relating to recovery support services for substance use disorders and co-occurring conditions (i.e., mental health conditions coexisting with substance use disorders).
The section expands the center's functions to include professional development of peer support specialists and recovery support services in nonclinical settings. It also authorizes through FY2030 a regional technical assistance center to support the ability of the center to meet a particular region's needs.
(Sec. 303) This section reauthorizes through FY2030 grants to nonprofits for establishing or operating opioid recovery centers providing comprehensive treatment and recovery support services. The grant program is administered by SAMHSA.
(Sec. 304) This section reauthorizes through FY2030 and revises the Preventing Youth Overdose: Treatment, Recovery, Education, Awareness, and Training (PYO-TREAT) program, which is administered by SAMHSA. The PYO-TREAT program provides grants and other support to educational and public entities for substance use disorder prevention, treatment, and recovery for children and young adults.
The section revises the program to provide statutory authority for (1) requiring applicants to submit plans for sustaining activities under the program after the grant has ended, and (2) expanding eligible grant recipients to include consortia of local educational agencies. SAMHSA must report to Congress on the PYO-TREAT program’s effectiveness.
(Sec. 305) This section reauthorizes through FY2030 and expands the Treatment, Recovery, and Workforce Support program, which is administered by SAMHSA. This program provides grants to public and private nonprofit entities to support individuals in treatment and recovery for substance use disorders and co-occurring conditions to live independently and participate in the workforce.
The section authorizes using 5% of such grant funds for transportation services and requires grant recipients to report on the employment and earnings outcomes of program participants.
Also, the section reauthorizes through FY2030 the Recovery Housing Pilot Program, which assists states in providing individuals in recovery from a substance use disorder with stable, temporary housing for up to two years. This program is administered by the Department of Housing and Urban Development.
(Sec. 306) This section reauthorizes through FY2030 the Support to Communities: Fostering Opioid Recovery through Workforce Development program, which is administered by the Department of Labor. This program provides grants to public entities to address the economic and workforce-related impacts of substance use disorders through activities such as screening and support services, training, and engaging with employers.
(Sec. 307) This section requires HHS to convene a public meeting relating to improving awareness of and access to grants provided by SAMHSA. Based on the stakeholder feedback received at the meeting, HHS must implement improvements to relevant websites and report to Congress.
TITLE IV--MISCELLANEOUS MATTERS
(Sec. 401) This section allows pharmacies to deliver to prescribing practitioners schedule III-V controlled substances that are not directly administered by the practitioner (i.e., self-administered), provided the controlled substances are subject to a risk evaluation and mitigation strategy to assure safe use by the patient, including post-administration monitoring by a health care provider.
(Sec. 402) This section expands the types of organizations that may provide training or education required for practitioners registering with the DEA to dispense (i.e., prescribe or administer) schedule II-V controlled substances. This section applies retroactively, taking effect as if enacted on December 29, 2022.
Show less of the summaryIncludes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
House · Jun 4, 2025 · Roll call 151 · Passed
House · Jun 4, 2025 · Roll call 150 · Failed · Amendment vote
Became Public Law No: 119-44.
Became Public Law No: 119-44
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Message on Senate action sent to the House.
Passed Senate without amendment by Unanimous Consent. (consideration: CR S6712)
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed by the Yeas and Nays: 366 - 57 (Roll no. 151). Roll call details
Passed/agreed to in House: On passage Passed by the Yeas and Nays: 366 - 57 (Roll no. 151). Roll call details
The House adopted the amendments en gros as agreed to by the Committee of the Whole House on the state of the Union.
The previous question was ordered pursuant to the rule.
Advisory bodies · Child health · Community life and organization · Computer security and identity theft · Congressional oversight · Drug trafficking and controlled substances · Drug, alcohol, tobacco use · Emergency communications systems · Employment and training programs · Family services · First responders and emergency personnel · Government information and archives · Government lending and loan guarantees · Government studies and investigations · Health care coverage and access · Health information and medical records · Health personnel · Health programs administration and funding · Health promotion and preventive care · Higher education · Housing and community development funding · Intergovernmental relations · Long-term, rehabilitative, and terminal care · Medical education · Medical research · Mental health · Prescription drugs · Social work, volunteer service, charitable organizations · State and local government operations · Student aid and college costs · Transportation costs · Women's health
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsThe House rose from the Committee of the Whole House on the state of the Union to report H.R. 2483.
The House resolved into Committee of the Whole House on the state of the Union for further consideration.
Considered as unfinished business. (consideration: CR H2456-2457)
Committee of the Whole House on the state of the Union rises leaving H.R. 2483 as unfinished business.
On motion that the committee rise Agreed to by voice vote.
Mr. Wittman moved that the committee rise.
DEBATE - Pursuant to the provisions of H.Res. 458, the Committee of the Whole proceeded with 10 minutes of debate on the Wittman amendment No. 4.
POSTPONED PROCEEDINGS - At the conclusion of debate on the Pettersen amendment, the Chair put the question on agreeing to the amendment and by voice vote, announced the noes had prevailed. Ms. Pettersen demanded a recorded vote, and the Chair postponed further proceedings until a time to be announced.
DEBATE - Pursuant to the provisions of H.Res. 458, the Committee of the Whole proceeded with 10 minutes of debate on the Pettersen amendment No. 3.
DEBATE - Pursuant to the provisions of H.Res. 458, the Committee of the Whole proceeded with 10 minutes of debate on the Kiggans (VA) amendment No. 2.
DEBATE - Pursuant to the provisions of H.Res. 458, the Committee of the Whole proceeded with 10 minutes of debate on the Bresnahan amendment No. 1.
GENERAL DEBATE - The Committee of the Whole proceeded with one hour of general debate on H.R. 2483.
The Speaker designated the Honorable Scott DesJarlais to act as Chairman of the Committee.
House resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 458 and Rule XVIII.
Rule provides for consideration of H.R. 2483, H.R. 2931, H.R. 2966 and H.R. 2987. The resolution provides for consideration of H.R. 2483 under a structured rule and for consideration of H.R. 2931, H.R. 2966, and H.R. 2987 under a closed rule. The resolution provides for one hour of debate and one motion to recommit on each bill.
Considered under the provisions of rule H. Res. 458. (consideration: CR H2441-2456; text: CR H2447-2543)
Rules Committee Resolution H. Res. 458 Reported to House. Rule provides for consideration of H.R. 2483, H.R. 2931, H.R. 2966 and H.R. 2987. The resolution provides for consideration of H.R. 2483 under a structured rule and for consideration of H.R. 2931, H.R. 2966, and H.R. 2987 under a closed rule. The resolution provides for one hour of debate and one motion to recommit on each bill.
Placed on the Union Calendar, Calendar No. 84.
Committee on Financial Services discharged.
Committee on Financial Services discharged.
Committee on the Judiciary discharged.
Committee on the Judiciary discharged.
Committee on Education and Workforce discharged.
Committee on Education and Workforce discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-114, Part I.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-114, Part I.
Ordered to be Reported (Amended) by the Yeas and Nays: 36 - 13.
Committee Consideration and Mark-up Session Held
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, the Judiciary, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, the Judiciary, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, the Judiciary, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, the Judiciary, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Coverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
255 citations; showing the 25 most recently posted.
TRUST FOR AMERICA'S HEALTH · lobbying firm or registrant: TRUST FOR AMERICA'S HEALTH
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 22, 2026 · issue area: Health Issues
$45,651
Spent on own lobbying
…tion (Not yet introduced) 21.Public Health Infrastructure Saves Lives Act (Not yet introduced) 22.The Support for Patients and Communities Reauthorization Act (H.R. 2483/S.2121) 23.The PEER Support Act (H.R.2741/S.1329) 24.The Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act (S.93…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
TRUST FOR AMERICA'S HEALTH · lobbying firm or registrant: TRUST FOR AMERICA'S HEALTH
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · amended · posted Oct 22, 2026 · issue area: Health Issues
$45,945
Spent on own lobbying
…tion (Not yet introduced) 21.Public Health Infrastructure Saves Lives Act (Not yet introduced) 22.The Support for Patients and Communities Reauthorization Act (H.R. 2483/S.2121) 23.The PEER Support Act (H.R.2741/S.1329) 24.The Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act (S.93…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · lobbying firm or registrant: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Alcohol and Drug Abuse
$393,240
Spent on own lobbying
…and Human Services to issue guidance on whether hospital emergency departments should implement routine fentanyl testing for patients experiencing an overdose H.R. 2483-Support for Patients and Communities Reauthorization Act, to reauthorize grants and programs to address opioid and substance use disorder H.R. 7994-Helping Edu…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
MENTAL HEALTH AMERICA · lobbying firm or registrant: ALPINE GROUP PARTNERS, LLC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$10,000
Paid to lobbying firm
…/H.R.7708 REAL Health Providers Act Community Mental Health Services Block Grant Issues related to youth peer support services H.R. 1735/S. 779 EARLY Minds Act H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
MENTAL HEALTH AMERICA · lobbying firm or registrant: ALPINE GROUP PARTNERS, LLC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$10,000
Paid to lobbying firm
…/H.R.7708 REAL Health Providers Act Community Mental Health Services Block Grant Issues related to youth peer support services H.R. 1735/S. 779 EARLY Minds Act H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
MENTAL HEALTH AMERICA · lobbying firm or registrant: ALPINE GROUP PARTNERS, LLC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$10,000
Paid to lobbying firm
…/H.R.7708 REAL Health Providers Act Community Mental Health Services Block Grant Issues related to youth peer support services H.R. 1735/S. 779 EARLY Minds Act H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
JOHNSON & JOHNSON SERVICES INC · lobbying firm or registrant: JOHNSON & JOHNSON SERVICES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Pharmacy
$2,220,000
Spent on own lobbying
- H.R. 2483, "SUPPORT for Patients and Communities Reauthorization Act of 2025", regarding all provisions.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.) · lobbying firm or registrant: NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$1,520,000
Spent on own lobbying
…ds Access to Care Act H.R. 1735 / S. 779, The Early Action and Responsiveness Lifts Youth (EARLY) Minds Act H.R. 2587/S. 1266, Youth Mental Health Research Act H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act H.R.3255/S.1673, Mental Health Infrastructure Act Issues related Pub. L No. 119-21; specifically stat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · lobbying firm or registrant: FAEGRE DRINKER BIDDLE & REATH LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Pharmacy
$30,000
Paid to lobbying firm
…Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ALLIANCE ON MENTAL ILLNESS · lobbying firm or registrant: NATIONAL ALLIANCE ON MENTAL ILLNESS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$10,000
Spent on own lobbying
…g addiction. S. 266/H.R. 929: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act continues education and awareness for mental health services. H.R. 2483: SUPPORT for Patients and Communities Reauthorization Act of 2025 extends and expands grants for serious mental illness and substance use disorder. Support for…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NAADAC, THE ASSOCIATION FOR ADDICTION PROFESSIONALS · lobbying firm or registrant: WHEAT SHROYER GOVERNMENT RELATIONS LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$10,000
Paid to lobbying firm
(H.R.2483/S.2121) SUPPORT for Patients and Communities Reauthorization Act of 2025 Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization (…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN PSYCHIATRIC ASSOCIATION · lobbying firm or registrant: AMERICAN PSYCHIATRIC ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$144,050
Spent on own lobbying
…th Care Access Act of 2025 H.R. 4619 - Medicare Mental Health Inpatient Equity Act S. 1062 - Suicide Prevention Act H.R. 912 - 9-8-8 Lifeline Cybersecurity Act H.R. 2483/S.2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 3655 - STAR Plus Scholarship Act H.R. 3885/S.3989 - Community TEAMS Act H.R. 316…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
COUNTY OF SANTA BARBARA · lobbying firm or registrant: THOMAS WALTERS & ASSOCIATES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Government Issues
$24,000
Paid to lobbying firm
…ican Dream (ROAD) to Housing Act. H.R. 6644, the Housing for the 21st Century Act. H.R. 4669, the Fixing Emergency Management for Americans (FEMA Act) of 2025. H.R. 2483, the SUPPORT Act of 2025 H.R. 7437, the Bridges And Safety Infrastructure for Community Success (BASICS) Act. Outer Continental Shelf Oil and Gas leases S. 352…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
COUNTY OF VENTURA · lobbying firm or registrant: THOMAS WALTERS & ASSOCIATES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Government Issues
$60,000
Paid to lobbying firm
…for the 21st Century Act. H.R. 4669, the Fixing Emergency Management for Americans (FEMA Act) of 2025. the Second Chance Reauthorization Act of 2025 (S. 1843), H.R. 2483, the SUPPORT Act of 2025 H.R. 7437, the Bridges And Safety Infrastructure for Community Success (BASICS) Act. OMB Proposed rule on Uniform grant guidance Farm…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
MASSACHUSETTS MEDICAL SOCIETY · lobbying firm or registrant: MASSACHUSETTS MEDICAL SOCIETY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$50,000
Spent on own lobbying
…no specific bill (including H.R.1) Opioids/ Substance Use Disorder MATE ACT Adds New Education Mandate for 8 Hours of Continuing Education on Opioid Treatment H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act S.4941 Modernizing Opioid Treatment Access Act 2.0 of 2026 Issues related to opioids and substance use…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
MASSACHUSETTS MEDICAL SOCIETY · lobbying firm or registrant: MASSACHUSETTS MEDICAL SOCIETY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Medicare/Medicaid
$50,000
Spent on own lobbying
…no specific bill (including H.R.1) Opioids/ Substance Use Disorder MATE ACT Adds New Education Mandate for 8 Hours of Continuing Education on Opioid Treatment H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act S.4941 Modernizing Opioid Treatment Access Act 2.0 of 2026 Issues related to opioids and substance use…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
MASSACHUSETTS MEDICAL SOCIETY · lobbying firm or registrant: MASSACHUSETTS MEDICAL SOCIETY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Alcohol and Drug Abuse
$50,000
Spent on own lobbying
…Disorder MATE ACT Adds New Education Mandate for 8 Hours of Continuing Education on Opioid Treatment S.4941 Modernizing Opioid Treatment Access Act 2.0 of 2026 H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act Issues related to opioids and substance use disorder - no specific bill
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN MEDICAL ASSOCIATION · lobbying firm or registrant: AMERICAN MEDICAL ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$4,540,000
Spent on own lobbying
…ation Prevention Act, all provisions H.R.2191 - Physician Led and Rural Access to Quality Care Act, all provisions H.R.2332 - SHARE Act of 2025, all provisions H.R.2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025, all provisions H.R.2850 - Youth Sports Facilities Act of 2025, all provisions H.R.3022 - Re…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLARK COUNTY NV (OFFICE OF THE COUNTY MANAGER) · lobbying firm or registrant: MARCUS G. FAUST, PC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Health Issues
$40,000
Paid to lobbying firm
●Nominations for Administration positions, including hearings and confirmations by the U.S. Senate ●H.R.2483/ S.2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025 ●H.R.1510/ S.1720 - Due Process Continuity of Care Act ●H.R.2586 - Reentry Act of 20…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ACADEMY OF FAMILY PHYSICIANS · lobbying firm or registrant: AMERICAN ACADEMY OF FAMILY PHYSICIANS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Health Issues
$499,510
Spent on own lobbying
…ment Act (H.R. 2559/S. 1420) - Child Care Nutrition Enhancement Act (H.R. 2495/S. 1971) - Nutrition Counseling Aiding Recovery for Eating Disorders (CARE) Act (H.R. 2483) - SUPPORT for Patients and Communities Reauthorization Act (H.R. 2762/S. 1394) - Expanding Access to Family Planning Act (H.R. 2717/S. 1320) - Servicewoman an…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHYSICIAN ASSISTANT EDUCATION ASSOCIATION · lobbying firm or registrant: PHYSICIAN ASSISTANT EDUCATION ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 14, 2026 · issue area: Health Issues
$150,000
Spent on own lobbying
Workforce development and clinical training site issues Issues surrounding opioid use disorders and medication-assisted treatment H.R. 2483/S.2121 - SUPPORT for Patients and Communities Reauthorization Act H.R. 3170 - Improving Access to Workers' Compensation for Injured Federal Workers Act H.R. 42…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COUNCIL FOR BEHAVIORAL HEALTH · lobbying firm or registrant: NATIONAL COUNCIL FOR BEHAVIORAL HEALTH
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 12, 2026 · issue area: Health Issues
$140,923
Spent on own lobbying
SUPPORT for Patients and Communities Reauthorization Act (H.R. 2483), all provisions related to the continued bolstered funding for substance use disorder treatment and recovery. Ensuring Excellence in Mental Health Act (S.3402…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS · lobbying firm or registrant: AMERICAN COLLEGE OF EMERGENCY PHYSICIANS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 30, 2026 · issue area: Alcohol and Drug Abuse
$498,299
Spent on own lobbying
…and Human Services to issue guidance on whether hospital emergency departments should implement routine fentanyl testing for patients experiencing an overdose H.R. 2483-Support for Patients and Communities Reauthorization Act, to reauthorize grants and programs to address opioid and substance use disorder S.921-Tylers Law, to…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.) · lobbying firm or registrant: NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$1,370,000
Spent on own lobbying
…ds Access to Care Act H.R. 1735 / S. 779, The Early Action and Responsiveness Lifts Youth (EARLY) Minds Act H.R. 2587/S. 1266, Youth Mental Health Research Act H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act H.R.3255/S.1673, Mental Health Infrastructure Act Issues related Pub. L No. 119-21; specifically stat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
JOHNSON & JOHNSON SERVICES INC · lobbying firm or registrant: JOHNSON & JOHNSON SERVICES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Pharmacy
$1,440,000
Spent on own lobbying
- H.R. 2483, "SUPPORT for Patients and Communities Reauthorization Act of 2025", regarding all provisions.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing